Interleukin (IL)-3, IL-5 and granulocyte-macrophage colony-stimulating factor (GM-CSF) regulate proliferation, dierentiation and apoptosis of target cells. Receptors for these cytokines consist of a cytokinespeci®c a subunit and a common shared bc subunit. Tyrosine phosphorylation of the bc is thought to play a critical role in mediating signal transduction events. We have examined the eect of mutation of bc tyrosines on the activation of multiple signal transduction pathways. Activation of protein kinase B (PKB) required JAK2 and was inhibited by dominant-negative phosphatidylinositol 3-kinase (P13K). Overexpression of JAK2 was sucient to activate both protein kinase B (PKB) and extracellular regulated kinase-1 (ERK1). Tyrosine 577 and 612 were found to be critical for the activation of PKB and ERK1, but not activation of STAT transcription factors. Activation of both PKB and ERK have been implicated in the regulation of proliferation and apoptosis. We generated GM-CSFR stable cell lines expressing receptor mutants to evaluate their eect on these processes. Activation of both PKB and ERK was perturbed, while STAT activation remained unaected. Tyrosines 577 and 612 were necessary for optimal proliferation, however, mutation of these tyrosine residues did not aect GM-CSF mediated rescue from apoptosis. These data demonstrate that while phosphorylation of bc tyrosine residues 577 and 612 are important for optimal cell proliferation, rescue from apoptosis can be mediated by alternative signalling routes apparently independent of PKB or ERK activation.
Introduction
The cytokine receptor family that consists of the receptors for interleukin (IL)-3, IL-5 and granulocytemacrophage colony-stimulating factor (GM-CSF) have a cytokine-speci®c alpha chain (IL-3Ra, IL-5Ra and GM-CSFRa) and a common beta chain, bc, which are both required for high anity ligand binding. The biological eects of these cytokines on haemopoietic cell lineages and their precursors include induction of proliferation, dierentiation, in¯ammation, cell adhesion, regulation of eector functions and rescue from apoptosis (reviewed by Arai et al., 1990; Lopez et al., 1992; De Groot et al., 1998) . Recent data has also implicated this family of cytokines in the pathogenesis of various leukaemia's. A naturally occurring truncated isoform of bc has been identi®ed in a signi®cant proportion of patients with acute leukaemia (Gale et al., 1998) , while it has also been demonstrated that inhibition of GM-CSF prevents dissemination and induces remission of myelomonocytic leukaemia (Iversen et al., 1997) . Surprisingly, expression of the GM-CSF receptor has also been found in human prostate cancer implying that prostatic tissues may also be responsive to GM-CSF (Rivas et al., 1998) .
Signal transduction events elicited by each of these cytokines are thought to be similar, since they all utilize the common bc (Lopez et al., 1992) . Although no speci®c signalling events have been attributed to the a-chains, intracellular truncation results in aberrant signal transduction (Takaki et al., 1994; Polotskaya et al., 1994) . The bc does not possess intrinsic tyrosine kinase activity, but associates with a cytoplasmic tyrosine kinase, JAK2 (Janus Kinase 2), via the membrane proximal region (Quelle et al., 1994) . Following cytokine stimulation, the receptor multimerizes, allowing trans-phosphorylation of the bc, resulting in the recruitment of signalling molecules to the bc and activation of downstream signalling events (Quelle et al., 1994; Zhao et al., 1995; De Groot et al., 1998) . The precise mechanisms and speci®c tyrosine residues involved remain to be fully elucidated. The bc contains docking sites for SH2-domain containing proteins such as the cytoplasmic transcription factors STATs (signal transducers and activators of transcription; reviewed by Darnell, 1997) . However, there is a high redundancy for STAT binding sites on the cytoplasmic bc; mutation of a single tyrosine residue does not aect STAT activation (Durstin et al., 1996; Van Dijk et al., 1997) .
Another critical signalling pathway activated by IL-3/IL-5/GM-CSF is initiated by the lipid kinase PI3K, which phosphorylates phosphoinositides on the 3' position (Corey et al., 1993; Sato et al., 1993; Gold et al., 1994; Coer et al., 1998a,b) . Phosphatidylinositol (PI) lipids are known to be critical for the activation of several protein kinases including protein kinase B/c-Akt (PKB), and the recently identi®ed PDK1 (PtdIns(3,4,5)P 3 dependent protein kinase; Alessi et al., 1997; Stephens et al., 1998) . Pathways associated with PI3K have been linked to both proliferation through p70 S6K (Calvo et al., 1994) , as well as the rescue from apoptosis through PKB (Kauman-Zeh et al., 1997; Datta et al., 1997; Del Peso et al., 1997) , although the precise mechanism by which PI3K is activated through the bc still needs to be elucidated. Since various candidates regulating bc activation of PI3K have been reported, it is likely that there are multiple pathways from the bc that can trigger activation of PI3K depending on cell type (Welham et al., 1994; JuÈ cker and Feldman, 1995; Odai et al., 1995; Chin et al., 1997; Anderson et al., 1997) .
In this study, we have investigated which tyrosine residues in the common bc are important for activation of PI3K-mediated signalling events in comparison with activation of the ERK MAP kinases and the STAT transcription factors. We have also assessed the role of bc tyrosine residues in proliferation, as well as in rescue from apoptosis induced by GM-CSF. We have demonstrated for the ®rst time that activation of PKB by IL-5/GM-CSF/IL-3 requires the phosphorylation of speci®c bc tyrosine residues. Furthermore, while activation of this signalling pathway may play a role in regulation of proliferation, inability to activate PKB does not appear to dramatically deregulate apoptosis. These data provide new insights into the mechanisms of activation and function of bc-mediated signal transduction.
Results
Activation of PKB and ERK1 requires the bc tyrosine residues 577 and 612
The mechanisms of PI3K activation by bc are ill-de®ned (see De Groot et al., 1998) . We and others have previously identi®ed PKB as a downstream eector of PI3K activity stimulated by growth factors (Burgering and Coer, 1995; Franke et al., 1995) and that PKB is activated by IL-5 and IL-3 in both cell lines and human granulocytes, although the mechanisms have not been de®ned (Songyang et al., 1997; Coer et al., 1998b) . To analyse the mechanism by which bc can activate PKB we transiently transfected Rat1 cells with IL-5Ra and bc together with epitope-tagged PKB (HA_PKB) and analysed PKB kinase activity in vitro. These cells have no endogenous bc and demonstrate a relatively strong activation of PI3K pathways by growth factors (Burgering and Coer, 1995) , thus being a suitable Figure 1 Activation of multipe signalling pathways in response to IL-5. (a) Rat1 cells were transiently transfected with HA_PKB (2 mg), IL-5Ra (2 mg) together with bc (2 mg; lanes 1, 2, 5, 6) or bcDbox (2 mg; lanes 3, 4) plus empty vector (4 mg; lanes 1, 2, 5, 6) or dominant-negative p85 (4 mg; Dp85; lanes 5, 6), kinase-dead JAK2 (2 mg; dnJAK2; lanes 7, 8). Forty-eight hours after transfection serum-starved cells were left unstimulated or stimulated with hIL-5 (5610 710 M) for 7 min, HA_PKB was immunoprecipitated and an in vitro kinase assay was performed using Histone 2B (H2B) as a substrate. H2B and autophosphorylated PKB are indicated. (b) Rat1 cells were transfected with bc tyrosine mutants (10 mg) and the bc was immunoprecipitated, blotted and bc expression detected with a bc antibody (left panel). For in vitro kinase assays cells were transfected as indicated and stimulated as described above. Equal expression of PKB was determined by 12CA5 Western blotting (lower right panel). (c) Rat1 cells were transfected with HA_ERK1 (2 mg) and bc tyrosine mutants as indicated and stimulated as described above. HA_ERK was immunoprecipitated and an in vitro kinase assay was performed using myelin basic protein (MBP) as a substrate. (d) Rat1 cells were transiently transfected with IL-5Ra and either of the bc mutants together with a tkCAT reporter plasmid (4 mg) containing 46IRE STAT binding sites (lane 1, wt bc; lane 2, bc DboxI/II; lane 3, DY577; lane 4, DY612; lane 5, DY577/612). Thirty-six hours after transfection cells were left unstimulated or hIL-5 was added to the cells overnight and CAT activity was determined the next day as described in Materials and methods. The fold induction is indicated as the amount of CAT activity of the hIL-5 stimulated cells compared to the unstimulated cells model system. As shown in Figure 1a , PKB is activated following IL-5 stimulation. This activation is mediated through PI3K, as cotransfection of dominant negative PI3K (Dp85; Hara et al., 1994) blocks IL-5 dependent PKB activation. To determine whether IL-5 dependent PKB activation required tyrosine phosphorylation of the bc we cotransfected bc that had a deletion of box I and II, which prevents the binding of JAK2 and thus prevents receptor phosphorylation (Quelle et al., 1994; Tanner et al., 1995) . We found that box I/II of bc are critical for the activation of PKB, since deletion almost completely abrogated PKB activation (Figure 1a , left panel). To rule out the possibility that this abrogation is due to a generally non-functional receptor we also transfected kinase-dead JAK2, which has previously been described to function as a dominant-negative mutant (Briscoe et al., 1996) . Overexpression of this mutant of JAK2 indeed dramatically decreased activation of PKB (Figure 1a , right panel). To determine if tyrosine residues 577 or 612 were responsible for mediating activation of PKB, we transfected cells with bc containing either single or double point mutations of these residues. While activation of PKB was mediated predominantly by bc tyrosine residue-577, tyrosine-612 also appears to play a minor role, since activation is only completely blocked by mutation of both tyrosines ( Figure 1b) . Similar results were also obtained by transfecting 293 cells (data not shown). Re-hybridizing the same blot revealed equal expression of PKB in all lanes. We also veri®ed whether expression of the various bc constructs was equal (Figure 1b, left panel) .
Previous work has demonstrated a potential role for Shc binding to tyrosine-577 as a mechanism of initiating MAP kinase activation (Durstin et al., 1996; Itoh et al., 1996; Pratt et al., 1996) . To determine if the same tyrosine residues were indeed necessary for activation of the MAP kinase, ERK1, we performed similar cotransfection experiments. ERK1 activation also required an intact box I/II region and was dependent on p21 ras (data not shown). Mutation of tyrosine-577 abrogated ERK1 activation (Figure 1c ), suggesting this tyrosine is also critical for activation of ERK1.
To demonstrate that the bc with mutations in these tyrosine residues is still functional in the activation of other signalling pathways we analysed activation of STAT transcription factors. For this purpose we transiently transfected cells with IL-5Ra and bc mutants together with a tkCAT reporter plasmid containing 46IRE binding sites and analysed the induction of CAT activity by IL-5. We have previously demonstrated that this is a speci®c STATbinding reporter construct (Caldenhoven et al., 1994) . While neither bc tyrosine mutant aected STAT activation, the bc DboxI/boxII mutant completely abrogated IL-5 mediated STAT activation ( Figure  1d ). Thus, while STAT activation appears to allow redundancy in bc phosphotyrosine residues, p21
ras -ERK and PI3K-PKB signalling require tyrosine phosphorylation of speci®c bc residues.
Overexpression of JAK2 activates both PKB and ERK1
As we found that JAK2 binding and phosphorylation of the bc is required for both PKB and ERK activation (Figure 1 ), we next addressed whether JAK2 overexpression itself was sucient to activate these signalling pathways, as has previously been demonstrated for STATs (Winston and Hunter, 1995) . JAK2 was overexpressed in Rat1 cells and ERK1 or PKB assays were performed. Interestingly, increased JAK2 expression was sucient to activate both ERK1 (Figure 2a , compare lane 1 and 3) or PKB ( Figure  2b , compare lane 1 and 3), indicating that overexpression of JAK2 is sucient to activate downstream signalling pathways. Overexpression of JAK2, however, did not result in a`superinduction' of ERK1 and PKB activity in the presence of IL-5 (Figure 2a and b, compare lanes 2 and 4). This suggests that either the level of bc phosphorylation is playing a limiting role or perhaps more likely, that this activation is independent of bc.
Expression of bc in BaF3 cell lines and activation of signalling pathways
Activation of both PI3K and MAP kinase have been proposed to be critical for both proliferative and antiapoptotic eects of IL-5/GM-CSF/IL-3 (Okuda et al., 1994; Perkins et al., 1996; Songyang et al., 1997; Kinoshita et al., 1997) . To analyse the potential function of bc tyrosine residues 577 and 612 we utilized Ba/F3 cells, a mouse pre-B cell line that is dependent on murine IL-3 for its growth. As the IL5Ra subunit was found to interact with the endogenous mouse bc (data not shown) we generated polyclonal stable cell lines with the GM-CSFRa subunit alone, which did not interact with endogenous mouse bc (see Figure 3a ), or together with either wildtype human bc (hbc) or hbc in which either tyrosine-577 (D577), 612 (D)612) or both (D577/612) had been mutated. Expression of the hbc in the Ba/F3 cell lines was veri®ed by immunoprecipitation with an antibody that speci®cally recognizes the hbc. Figure 3a demonstrates that the expression in bc wt, D577, D612 and D577/612 is comparable. To analyse whether GM-CSF receptor signalling in these cell lines can be reconstituted, we ®rst analysed STAT activation following hGM-CSF stimulation, using an electromobility shift assay. Comparable STAT activity was seen following hGM-CSF stimulation in all stable cell lines except for the Ba/F3 cells expressing only GM-CSFRa, indicating that signalling of these hGM-CSF-R stable cell lines speci®cally utilizes the human bc (Figure 3b) . Moreover, STAT activity was not diminished in the BaF3 cells containing the hbc with tyrosine mutations. We then analysed PKB activation utilizing activation- , which is phosphorylated together with Thr 308 following activation of PKB (Stokoe et al., 1997; Haas-Kogan et al., 1998) . We found, in agreement with the data for the Rat1 cells, that activation is mediated predominantly through tyrosines 577 and 612, as the double tyrosine mutant was unable to phosphorylate PKB Ser 473 ( Figure 3c ). Addition of the PI3K inhibitor LY294002 completely abrogated PKB phosphorylation following mIL-3 in all GM-CSFR stable cell lines, indicating that phosphorylation of PKB on Ser 473 is indeed downstream of PI3K. Activation of ERK1 and ERK2 was also almost completely eliminated by mutation of these residues (Figure 3d ). Additional tyrosine residues may be involved in the activation of ERK1/2, since the D577/612 mutant still demonstrated a slight ERK2 activation, although activity was greatly reduced compared to the wildtype bc. Measuring activity of endogenous ERK2 using a substrate-based kinase assay yielded similar results (data not shown).
Optimal proliferative response to hGM-CSF requires bc tyrosines 577/612
GM-CSF induces cell proliferation and rescue from apoptosis in a dose-dependent manner. To determine whether mutation of tyrosine-577 and 612 aected proliferation of cells when grown on hGM-CSF, cells were grown for 3 days with two dierent concentrations of hGM-CSF and the cell numbers determined every 24 h. Cells expressing only the GM-CSFRa chain failed to proliferate when challenged with GM-CSF, demonstrating the necessity for interaction with the human bc (Figure 4) . No signi®cant eect was seen by mutating either tyrosine 577 or 612 independently. However, a 2 ± 3-fold decrease in proliferation was seen in Ba/F3 cells containing the bc D577/612. A slight, but reproducible, eect was also seen on the proliferation of the bc D577 cell line when the cells were grown on a lower concentration (10 712 M) hGM-CSF (Figure 4b ). To demonstrate that the eect on proliferation in the Ba/F3 bc D577/612 stable cell line is not a clonal artefact we also compared proliferation of this cell line with Ba/F3 bc wt when grown on mIL-3. No dierence in proliferation with mIL-3 was found between those cell lines (Figure 4c ), ruling out a clonal dierence between those cell lines. Thus it appears that while the ability to proliferate is not completely abrogated by mutation of tyrosine 577 and 612, it is substantially reduced. This suggests that activation of PI3K-PKB and/or MAP kinase may play a critical role in regulating bc-mediated proliferative responses. Since STATs are still activated in this bc mutant (Figure 3b) , it also suggests that they are not themselves sucient to mediate cytokine induced proliferative responses without cooperation with other signalling pathways.
GM-CSF mediated cell survival does not require bc tyrosines 577/612
In addition to inducing proliferation, agonists such as GM-CSF also prevent apoptosis in responsive cells. To investigate whether the decrease in proliferation that was seen in the D577/612 stable cell line was due to increased apoptosis, we determined the percentage of apoptotic cells after 48 h incubation with or without cytokine. Cells expressing only the GM-CSFRa chain exhibited no GM-CSF mediated rescue from apoptosis, although they could clearly be rescued by incubation with mIL-3 ( Figure 5 ). We did not observe a signi®cant decrease in the rescue from apoptosis in the single or double D577/612 cell lines following incubation with hGM-CSF (10 710 M), suggesting that these tyrosine residues are not necessary for mediating apoptotic rescue ( Figure 5 ). The same results were obtained at lower cytokine concentrations (10 712 M hGM-CSF; data not shown). Thus it appears that activation of PKB and ERK are not critical for GM-CSF mediated cell survival. It is possible that the small residual ERK activity present in the D577/612 may still contribute to the rescue from apoptosis, however, we did not ®nd a dierence in the rescue from apoptosis upon addition of the MEK inhibitor PD98059 (data not shown).
Discussion
Cytokines of the IL-5/GM-CSF/IL-3 family are important regulators of haemopoiesis through modulation of proliferation, dierentiation and survival of various haemopoietic cell lineages and their precursors Analysis of apoptosis in the Ba/F3 GM-CSFR stable cell lines. Ba/F3 cells containing the GM-CSFRa, GM-CSFRa and bc wt, D577, D612 or D577/612 were grown on hGM-CSF 10 710 M for 48 h and the percentage of apoptotic cells was determined as described in Materials and methods (Lopez et al., 1992; De Groot et al., 1998) . Although the receptors for these cytokines do not possess any intrinsic kinase activity, tyrosine phosphorylation of cellular substrates by bc-associated JAK kinases is rapidly observed in stimulated cells. One of these substrates is the bc itself, generating phosphotyrosine docking sites for SH2-containing downstream signalling molecules. In recent reports, as well as in this study, it has been shown that single mutation of any bc tyrosine residue has no eect on STAT activation by IL-5/GM/CSF/IL-3 suggesting a high degree of redundancy (Durstin et al., 1996; van Dijk et al., 1997 ; Figures 1d and 3b) .
In this paper we report that in various cell lines tyrosine 577 and 612 are important for the activation of both PKB and ERK. One pathway that induces activation of ERK is most likely mediated through the adapter protein Shc, which binds to phosphorylated tyrosine 577 on the bc and is itself tyrosine phosphorylated after IL-5/GM-CSF/IL-3 stimulation allowing Grb2-Sos binding and activation of p21 ras (Lanfrancone et al., 1995; Pratt et al., 1996; Itoh et al., 1996) . However, an alternative means of ERK activation may be initiated through SHP2, which has also been reported to interact through its SH2 domain with tyrosine 577 (Bone et al., 1997; Pazdrak et al., 1997; Okuda et al., 1997; Itoh et al., 1998) . Activation of ERK by SHP2 has also been suggested to occur through interaction of phosphorylated SHP2 with Grb2-Sos and subsequent p21 ras activation, observations that suggest redundancy in ERK activation (Pazdrak et al., 1997 ). An alternate means of ERK activation may also be provided by Shc binding directly to JAK2, which has been demonstrated for the erythropoietin (EPO) receptor (He et al., 1995) . This may explain the small residual ERK activity seen in the Ba/F3 bc D577/612 stable cell line (Figure 3d) .
Activation of PI3K through bc is complex and likely to be mediated through multiple signalling pathways. While the mechanisms of activation of its downstream eector PKB have not been previously investigated, PI3K activity has been found to be associated with anti-phosphotyrosine immunoprecipitates, but not with anti-bc immunoprecipitates (Sato et al., 1993) . Studies have reported binding of the regulatory subunit of PI3K to a novel, yet to be identi®ed protein (p80), that may link PI3K to the receptor (JuÈ cker and Feldman, 1995) , as well as by associating with lyn, a Src-like kinase that binds to the bc (Corey et al., 1993) . Furthermore, SHP2 was also found to bind to the p85 subunit of PI3K, potentially linking activation of both PI3K and p21 ras pathways (Welham et al., 1994) . The potential involvement of lyn in the activation of PI3K is of particular interest, s7ince this kinase has been linked to inhibition of apoptosis in human granulocytes and decreased lyn activity has been associated with an abrogation of PI3K activity (Youse® et al., 1996; Wei et al., 1996; Al Shami et al., 1997) . Together, this strongly suggests that there are multiple redundant pathways that promote activation of PI3K. Ourselves and others have previously demonstrated that PKB can be activated by cytokines of the IL-5/GM-CSF/IL-3 family (Songyang et al., 1997; Coer et al., 1998b) . However, this is the ®rst study to demonstrate the relevance of bc tyrosine residues in PI3K mediated signal transduction and activation of downstream targets such as PKB. Although we have shown that bc-mediated PKB activation requires the p85a subunit of PI3K (Figure 1a) , further studies are needed to determine precisely how PI3K is itself activated after cytokine stimulation.
Interestingly, we found that simply overexpression of JAK2 was sucient to induce activation of both PKB and ERK1 (Figure 2) . Overexpression of JAK2 in Ba/ F3 cells has previously been found to delay apoptosis (Sakai and Kraft, 1997) . In addition, abnormal activation of JAK2 has been implicated in acute lymphoblastic leukaemia (Meydan et al., 1996) . Thus overexpression or constitutive activation of JAK2 may lead to an inappropriate activation of p21 ras -ERK and PI3K-PKB, resulting in enhanced proliferation or cytokine-independent survival. A direct role for bc itself in leukaemogenesis has recently been implied by the recent observation that a truncated bc was found in patients with acute leukaemia (Gale et al., 1998) . This further suggests that inappropriate regulation of bc phosphorylation and thus downstream signalling events causes defective proliferation responses in some cells.
We have studied the eect of mutation of bc tyrosines 577 and 612 on proliferation and rescue of apoptosis. Whereas we did not ®nd an eect on cell survival with either of the mutants (Figure 5 ), we did observe a decrease in proliferation in the GM-CSFR D577/612 cell line (Figure 4) . Interestingly, recent reports have shown that inhibition of STAT activation in Ba/F3 cells, for example by overexpression of dominant-negative STAT5, signi®cantly repressed IL-3 dependent growth (Muli et al., 1996) . In contrast, we have demonstrated that repression of proliferation does not have to be linked with STAT activation, since the D577/612 cell line eectively activates STATs but has reduced proliferative capacity (Figure 4) . Our approach to determine the eects of the double tyrosine mutant bc has allowed the analysis of eects that may be overlooked with the single mutants. This may explain ®ndings of others suggesting that tyrosine 577 was not necessary for cell viability (Durstin et al., 1996; Itoh et al., 1998) . Since we demonstrated that tyrosines 577 and 612 on the bc were important for activation of both PKB and ERK, we were unable to distinguish their speci®c role using these tyrosine mutants. Recently, it has been shown that introduction of a dominant-negative MAP kinase kinase (MEK) in Ba/ F3 cells results in an increase in the level of IL-3 required to stimulate cell proliferation, suggesting a role for MAP kinase activation (Perkins et al., 1996) . However in other studies overexpression of dominant negative p21 ras N17 was not found to aect proliferation in Ba/F3 cells suggesting that MAPK activation is not necessary (Terada et al., 1995) . Furthermore, we have found addition of MEK inhibitor PD98059 did not aect proliferation in Ba/F3 cells (data not shown).
The fact that we did not observe a decrease in the rescue from apoptosis by hGM-CSF in the D577/612 stable Ba/F3 cell line, which fails to activate PKB may seem in apparent contrast with recently published data (Ahmed et al., 1997; Songyang et al., 1997) . Interestingly, our data indeed imply the potential for apoptotic rescue independently of PKB. Previous studies have relied on the overexpression of constitutively active PKB mutants, demonstrating a cytokineindependent rescue from apoptosis (Songyang et al., 1997) . It is dicult to determine the speci®city of these overexpression studies since constitutively active PKB is oncogenic and may induce autocrine or antiapoptotic eects in these cells and these data should thus be interpreted with caution. Furthermore it could be that PKB is sucient but not necessary to induce an anti-apoptotic program. A number of very recent studies have also demonstrated rescue from apoptosis independently of PKB (Scheid and Duronio, 1998; Kulik and Weber, 1998) . The development of convincing dominant-negative PKB mutants or speci®c pharmacological inhibitors will resolve this issue. Indeed we have recently found that overexpression of an eective dominant-negative PKB construct (PKB_CAAX; van Weeren et al., 1998) , in Ba/F3 cells did not aect IL-3 mediated rescue from apoptosis (data not shown).
The studies presented here provide insight not only into the mechanisms of bc-mediated signal transduction but also the potential role of these signalling pathways in maintaining proliferative capacity and viability of cytokine-dependent cells. Activation of PI3K and PKB by IL-5/GM-CSF/IL-3 has been previously demonstrated in cell lines and leukocytes (Ahmed et al., 1997; Songyang et al., 1997; Coer et al., 1998b) . This is the ®rst study to demonstrate a role for bc tyrosine residues in the activation of PKB and suggests speci®city between activation of PI3K-PKB, p21 ras -ERK and JAK-STAT signalling pathways. Furthermore, contrary to published ideas, our data implies that rescue from apoptosis can occur independently of PKB.
Materials and methods

Cells, reagents, antibodies
Rat-1 ®broblasts were cultured in Dulbecco's Modi®ed Eagle's medium (Gibco) supplemented with 8% heatinactivated FCS; Ba/F3 cells were cultured in RPMI 1640 supplemented with 8% Hyclone serum (Gibco) and recombinant mouse IL-3 (mIL-3) produced in COS cells (Caldenhoven et al., 1995) . Human IL-5 (hIL-5) was a kind gift of Dr D Fattah (Glaxo Wellcome group research, Stevenage, UK). Recombinant human GM-CSF was obtained from Genzyme (Boston, MA, USA). The constructs for p21 ras N17, Dp85, HA_PKB, HA_ERK1 (Burgering and Coer, 1995) and JAK2 (De Groot et al., 1997) have been described previously. Human IL-5Ra and human bc, as well as bc DboxI, bc DboxI/II, bc Y577G, bc Y612F and bc Y577G/Y612F mutants were cloned into expression vector pSG513 either with or without the hygromycin gene as described previously . PCDNA3-GMCSFRa (Polotskaya et al., 1993) and kinase-dead JAK2 were kind gifts of Dr A Kraft. Rabbit polyclonal antiserum against the human bc has been described previously . bc mAb, polyclonal ERK1 (C16) and rabbit polyclonal STAT3 (K-15) antibody were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Phospho-Ser 473 PKB and phospho-ERK antibodies were from New England Biolabs (Beverly, MA, USA).
Generation of stable transfectants
For the generation of polyclonal transfectants pcDNA3-GMCSFRa containing the neomycin resistance gene was electroporated into Ba/F3 cells (0.28 V; capacitance 960 mFD) together with either empty vector, bc wt, bc Y577G, bc Y612F or bc Y77G/612F cloned into pSG513 containing the hygromycin resistance gene. Cells were cultured in the presence of mIL-3 and selected in 500 mg/ml hygromycin and/or 500 mg/ml G418 (Boehringer Mannheim, Germany).
Western blotting and immunoprecipitation
For determining the presence of human bc in the Ba/F3 GM-CSFR stable cell lines 1.5610 7 cells were lysed in 20 mM Tris. NaCl pH 7.4, 150 mM HCl, 1% Triton X-100, 1 mM EDTA, 1 mM PMSF, 0.1 mM aprotinin and 1 mM sodium orthovanadate. Lysates were cleared by centrifugation at 48C and incubated with the appropriate antibody on a rotating wheel at 48C for 1 h. After that, Protein A beads were added and incubated for another hour. Protein A beads were washed three times with lysis buer and boiled in Laemli sample buer for 5 min at 958C. Subsequently, samples were run on SDS-polyacrylamide gels and proteins transferred to PolyVinyl DiFluoride (PVDF) membranes. Blots were incubated with appropriate antibodies and developed utilizing Enhanced Chemiluminescence (ECL, Amersham).
In vitro kinase assays
Cells were transfected transiently using calcium phosphate precipitation and the medium refreshed 8 h later. Thirty-six hours after transfection, the cells were transferred to 0.5% FCS overnight. After a further 12 h, the cells were stimulated with the appropriate stimulus, washed twice with cold PBS and lysed in a buer containing 1% Triton X-100, 50 mM Tris-HCl pH 7.5, 5 mM EDTA for ERK assays or 1% Triton X-100, 50 mM Tris-HCl pH 7.4, 100 mM NaCl, 5 mM EDTA for PKB assays, both supplemented with 10 mg/ml aprotinin, 1 mM leupeptin, 1 mM PMSF, 1 mM Na 3 VO 4 , 40 mM bglycerophosphate and 50 mM NaF. Kinase assays were performed as described previously (Burgering and Coer, 1995) .
CAT assays
Rat-1 cells (6-well plates) were transiently tranfected with 3 mg IL-5Ra and 3 mg bc (either wildtype or the tyrosine mutant 577, 612 or 577/612), together with 4 mg 46IREtkCAT reporter construct (Caldenhoven et al., 1996) . Thirty-six hours after transfection, cells were incubated overnight with IL-5 (10 710 M). Cells were washed with PBS and harvested in PBS/EDTA (25 mM) and lysed in 100 ml CAT buer (250 mM Tris-HCl pH 7.4, 25 mM EDTA). Membranes were spun down and 50 ml of the supernatant was incubated with 150 ml incubation buer (50 ml CAT buer, 7.5 ml 50% glycerol, 81.5 ml 250 mM TrisHCl pH 7.4, 10 ml 6.7 mg/ml butyrylCoA, 1 ml 14 C-Chloramphenicol 0.025 (mCi) for 2 h at 378C. Unincorporated 14 CChloramphenicol was separated from butyrylCoA using Xylene-Pristane (1 : 2) and 14 C-ButyrylCoA was counted. The fold induction was calculated as the amount of counts in the stimulated versus unstimulated cells (Caldenhoven et al., 1996) . Data represent the mean of three independent experiments+s.e.m.
Gel retardation assays
Nuclear extracts were prepared from 10 7 stimulated and unstimulated cells as described previously (Andrews and Faller, 1991) . Synthetic oligonucleotides of the FcgRI GAS (Caldenhoven et al., 1996) were labelled by ®lling in the cohesive ends with [a-32 P]dCTP using the Klenow fragment of DNA polymerase I. Gel retardation assays were carried out according to published procedures with slight modi®cations (Fried and Crothers, 1981) . Brie¯y, 5 mg nuclear extract were incubated in a ®nal volume of 20 ml, containing 10 mM HEPES pH 7.8, 50 mM KCl 2 , 1 mM EDTA, 5 mM MgCl 2 , 10% glycerol, 5 mM dithiothreitol, 2 mg poly (dI-dC) and 20 mg bovine serum albumin with 0.1 ± 1.0 ng of 32 P-labelled oligonucleotide for 20 min at room temperature. Subsequently, samples were run for 2 h on a 5% non-denaturing polyacrylamide gel at room temperature, vacuum-dried and exposed to Fuji RX ®lm at 7708C for 1 ± 2 days.
Apoptosis and proliferation assays
For apoptosis assays Ba/F3 cells were counted, washed twice with PBS and seeded in 24 well dishes (0.4610 6 cells per well). After 2 h cytokines were added and a further 48 h cells were harvested, washed twice in PBS and ®xed for 2 h in 300 ml PBS and 700 ml ethanol. Cells were spun down gently and permeabilized in 200 ml 0.1% Triton X-100, 0.045 M Na 2 HPO 4 and 0.0025 M sodium citrate at 378C for 20 min. Next, 750 ml apoptosis buer (0.1% Triton X-100, 10 mM PIPES, 2 mM MgCl 2 , 40 mg/ml Rnase, 20 mg/ml propidium iodide) was added and incubated for 30 min in the dark. 
